Skip to main content

International scientific guideline: ICH topic Q3A (R2) - Note for guidance on impurities testing: Impurities in new drug substances

CPMP/ICH/2737/99 adopted by the Therapeutic Goods Administration (TGA)

Help us improve the Therapeutic Goods Administration site